1 results match your criteria: "AP.HP.6 Pitie-Salpetriere University Hospital[Affiliation]"
Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review.
Front Pharmacol
February 2021
Sorbonne Université, Clinical Investigations Center Paris-Est, AP.HP.6 Pitie-Salpetriere University Hospital, INSERM, Paris, France.
In patients with allogenic hematopoietic stem cell transplantation (allo-HSCT), immune-checkpoint inhibitors (ICI) are used to treat malignancy recurrence. However, ICI are also associated with graft vs. host disease (GVHD).
View Article and Find Full Text PDF